Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Director/PDMR Shareholding

16 December 2020 18:15 GMT Transaction by Person Discharging Managerial Responsibilities Disclosure under Article 19 of the EU Market Abuse Regulation AstraZeneca PLC (the Company) announced that, on 16 December 2020, it was notified of transactions in the Company's Ordinary Shares of $0.25 each  by certain Persons Discharging Managerial Responsibilities (PDMRs) of the Company as set out below. PDMR Position Nature of the transaction Quantity PricePhilip Non Purchase of Ordinary Shares 1,310 GB£76.25Broadley -Executive Director

Calmark receives SEK 10.7 million through the redemption of warrants with an exercise rate of 98.1%

Calmark Sweden AB (publ) (“Calmark” or “the Company”) carried out a rights issue of shares and free-of-charge warrants during November 2019. The exercise period of the Series TO 2 B subscription warrants was between December 4, 2020, and December 16, 2020, and thus has ended. In total, 2,408,005 TO 2 B warrants were used to subscribe for shares, corresponding to an exercise rate of approximately 98.1 percent.In total, 2 408 005 subscription warrants, corresponding to approximately 98.1 percent of the total number, were used to subscribe for 2 408 005 B shares at a subscription price of SEK

Citycon decided on a quarterly distribution

CITYCON OYJ     Inside information     16 December 2020 at 19:30 hrsThe Board of Directors of Citycon Oyj has today decided, on the basis of the authorisation by the Annual General Meeting 2020, that an equity repayment of EUR 0.1250 per share will be distributed from the invested unrestricted equity fund of the company. The equity repayment will be paid to a shareholder registered in the company’s shareholders’ register maintained by Euroclear Finland Ltd on the record date of the repayment 18 December 2020. The equity repayment will be paid on 30 December 2020.On 28 May 2020 it was

Calliditas announces final outcome of simplified mandatory offer to the shareholders of Genkyotex

Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX - CALTX; NASDAQ - CALT) submitted a simplified public mandatory offer to the shareholders of Genkyotex on 26 November 2020. After the end of the acceptance period on December 11, Calliditas now controls 86.2 percent of the shares in Genkyotex.Calliditas acquired 7,236,515 ordinary shares in Genkyotex SA (“Genkyotex”) (Euronext Paris & Brussels: FR0013399474 - GKTX) on November 3, 2020, corresponding to 62.7 percent of the share capital and voting rights, from Genkyotex's largest shareholders and management group. On November 26,

Staffordshire University set to expand family-friendly campus with new net carbon zero Nursery and Forest School

Staffordshire University has revealed exciting plans for a £4.4m new woodland nursery and forest school that will offer places for the children of students, staff, and the local community.Located close to the University’s nature reserve at the heart of its Leek Road site, the new facilities will meet the high student and staff demand for nursery places whilst also providing additional places for the wider local community.  More than doubling the nursery’s existing capacity, the new provision will see 100 full day-care places for children aged from 0 to five delivered. It will also have

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 16.12.2020

United Bankers Corporation NOTIFICATION 16.12.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 16.12.2020 Date 16.12.2020Exchange transaction BuyShare class UNIAVAmount 474Average price/share 9.9378 EURHighest price/share 10.0000 EURLowest price/share 9.9000 EURTotal price 4,710.52 EUR The shares held by United Bankers Corporation on 16.12.2020: UNIAV 35,586   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Novel principle for cancer treatment shows promising effect

Researchers at Karolinska Institutet in Sweden report in the journal Nature that they have developed novel first-in-class inhibitors that compromise mitochondrial function in cancer cells. Treatment with the inhibitors stopped cancer cells from proliferating and reduced tumour growth in mice, without significantly affecting healthy cells.“We are excited to have shown that this novel principle for cancer treatment works in animal models and hopefully the inhibitors can now be developed further for anti-cancer treatment in humans,” says Nils-Göran Larsson, professor at the Department of

BERGENBIO TO PRESENT AN UPDATE ON THE ONGOING PHASE II STUDY OF BEMCENTINIB IN COMBINATION WITH PEMBROLIZUMAB IN REFRACTORY NSCLC AT WCLC 2020

Bergen, Norway, 16 December 2020 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce it has been accepted for an oral presentation at the 2020 World Conference on Lung Cancer Singapore (WCLC), being held from 28-31 January 2021. The oral presentation will provide an update from the Company's Phase II study of bemcentinib in combination with anti-PD-1 therapy pembrolizumab (BGBC008) in refractory non-small cell lung cancer (NSCLC). Abstract titles have been

Information regarding change of control in respect of bonds issued by SSM and redemption

On December 15, 2020 Amasten Fastighets AB (publ) (“Amasten”) completed the public tender offer to the shareholders in SSM and acquired 97.5 per cent of the shares and votes in SSM. Amasten’s acquisition of the shares in SSM is deemed a change of control pursuant to the terms and conditions of SSM’s outstanding bonds. As previously announced, SSM intends to fully redeem its outstanding bonds on January 8, 2021. Consequently, the bonds will not be listed with Nasdaq First North as previously announced.On December 8, 2020 SSM exercised its right to a voluntary total redemption of the

#20-454 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Calmark signs distributor agreement with LabForce in Switzerland

Calmark Sweden AB (publ) has entered an exclusive distributor agreement with the company LabForce AG regarding marketing and sales of the Calmark POC system on the Swiss market.The company LabForce began operations in 1999 and specializes in selling reagents and laboratory equipment for use in cellular and molecular biology, pathology and diagnostics. The company operates in the customer segments that are important to Calmark, and sells medical devices to hospitals, laboratories and the manufacturing industry. “LabForce is a well-established distributor that is making a great effort to

#20-453 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

FLNG – Repurchase of shares

December 16, 2020 Hamilton, Bermuda Flex LNG Ltd. (“Flex LNG” or the “Company”) announces that the Company has today purchased 1,500 of the Company’s own common stocks. The shares have been bought on the Oslo Stock Exchange at an average price of NOK 75.38 per share. After this transaction Flex LNG holds a total of 115,500 own shares. The transaction is part of the share buyback program announced on November 19, 2020. For more info please contact: Harald Gurvin, Chief Financial Officer of Flex LNG Management AS. Telephone +47 23 11 40 00 This information is subject to the

Securitas acquires FE Moran Security Solutions in the U.S.

Securitas has acquired FE Moran Security Solutions, a top 30 alarm monitoring and electronic security systems integration company in the U.S. The acquisition increases Securitas’ density and offerings in the United States’ Midwest region and is aligned with Securitas’ ambition to double the size of its security solutions and electronic security business. The purchase price is app. MUSD 82 (MSEK 695).Founded in 2003, FE Moran Security Solutions provides an integrated electronic security offering – from design to installation and from maintenance to alarm monitoring – and focuses on

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, stock exchange release, 16 December 2020 at 5:30 pm EETNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation BlackRock, Inc. has informed Wärtsilä Corporation that it has crossed below the 5% disclosure limit on total holding in shares and voting rights on 15 December 2020. Total position of BlackRock, Inc. and its funds subject to the notification: % of % of shares Total of Total number of shares shares and voting both in % and voting

The Board of Directors of Konecranes Plc has resolved the criterion for the second measurement period of the Performance Share Plan 2020

KONECRANES PLC STOCK EXCHANGE RELEASE December 16, 2020 at 17:30 EET The Board of Directors of Konecranes Plc has resolved the criterion for the second measurement period of the Performance Share Plan 2020 The Board of Directors of Konecranes Plc has resolved adjusted earnings per Share (EPS) as the criterion for the second measurement period of the Performance Share Plan 2020. Adjustments to the EPS include defined restructuring costs, mergers and acquisitions related deal costs and other unusual items. Performance Share Plan 2020 includes three separate measurement periods and

Ahlsell Norge AS acquires local retailer in Trondheim

Ahlsell Norge AS has entered into an agreement to acquire all shares in the company Tromas AS. The company has an annual turnover of approximately NOK 63 million.Since the start in 1992, Tromas has provided the construction industry in Trøndelag with tools and fastening products, and the 17 employees are located in the outlet and service station in Fossegrenda in Trondheim. Through the acquisition Ahlsell strengthens its presence in the region and becomes an even more effective partner for all players in the construction sector. This will give the customers the opportunity to order

First All-In-One Liquid Cooling Solutions from Phanteks Incorporate Asetek’s Most Advanced Liquid Cooling Technology

Aalborg, Denmark – December 16, 2020 –– Asetek, the creator of the all-in-one liquid (AIO) cooler and the global leader in liquid cooling solutions for gaming PCs and DIY enthusiasts, announced that new OEM partner Phanteks has introduced its first AIO CPU coolers, leveraging the superior thermal and acoustic performance and reliability associated with Asetek’s most advanced technology to date. The Phanteks Glacier One coolers provide advanced CPU overclocking capability, RGB lighting, and virtually silent operation to tech enthusiasts, gamers, and eSports pros. When defining its initial

IN THE SPOTLIGHT: ABS Lectures on Ship Vibration to Athens Students

ABS Greece was invited by Professors Lampros Kaiktsis and Christos Papadopoulos, of the National Technical University of Athens (NTUA), to deliver a lecture on ship vibration, entitled "Ship Vibration: What Went Wrong?"The 2-hour seminar was given to graduate and post graduate students in the school of Naval Architecture and Marine Engineering, while special external guests/specialists were also invited.Dr. Chris Leontopoulos, ABS Director of the Global Ship Systems Center, gave an overview of the principles of vibration and then went on to present five case studies,

SBB completes the acquisition of Finnish portfolio consisting of mainly elderly care properties – profit from property management increases by SEK 136m

The acquisition was signed on 15 October 2020 and has now been approved by the Finnish Competition Authority and the acquisition is thus unconditional, completion will take place on 17 December 2020. The portfolio comprises approximately 71,000 sq.m. of lettable area with a rental income of approximately EUR 13.6m and a net operating income of approximately EUR 13.1m. The average lease maturity of the portfolio is 7.6 years. The agreed property value for the portfolio amounts to EUR 222m. The properties are primarily located in southern and western Finland with 25 per cent of the

Exonet chooses Proact to deliver and support its new hosting platform

To respond to new types of customer demands the Dutch managed hosting provider, Exonet, have decided to update its hosting platform together with data and information management specialist, Proact.As a Dutch market leader within its field, Exonet hosts thousands of customers with business-critical websites and applications. To secure end-customers, downtime must be avoided - even during maintenance windows. As a growing business, Exonet’s underlying platform must be built on reliable, scalable infrastructure technology as well as covered by fast and reliable support services. “Although

Attana completes FDA Medical Device Class 1 listing and facility registration

Attana is pleased to announce today that it has completed a Medical Device listing of Attana Cell™ 250 and a facility registration of Attana, with the U.S. Food and Drug Administration (FDA).The facility registration and listing of Attana Cell™ 250 as a Class I device (510(k) exempt) are the first regulatory requirements for marketing Attana’s instruments towards the clinical diagnostics market. In 2021, Attana intends to complement these by filing for an FDA approval of at least one complementary assay as a Class II device, subject to 510(k) clearance. Simultaneous to these efforts, Attana

There are no items matching the current filter
There are no more items matching the current filter
Back to top